{"api":"v1","generated_at":"2026-10-01T02:44:14.699Z","licence":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/","attribution":"TOLL, with a link to the page cited"},"page":"https://tollindex.com/e/api-magentlab-com-api-calc-cll-ipi-602ef8","pinned_page":"https://tollindex.com/e/api-magentlab-com-api-calc-cll-ipi-602ef8/at/2026-09-30T22-14Z","pinned":false,"method":"https://tollindex.com/ledger/method","snapshot_at":"2026-09-30T22:14:11.940Z","snapshot_stamp":"2026-09-30T22-14Z","endpoint":{"slug":"api-magentlab-com-api-calc-cll-ipi-602ef8","canonical_url":"https://api.magentlab.com/api/calc/cll_ipi","resource":"https://api.magentlab.com/api/calc/cll_ipi","http_method":"POST","type":"http","x402_version":2,"registries":["cdp"],"primary_registry":"cdp","curated_by_coinbase":false,"description":"CLL-IPI 2016 for chronic lymphocytic leukaemia: TP53 abnormality (del(17p) and/or TP53 mutation) 4, unmutated IGHV 2, beta-2 microglobulin >3.5 mg/L 2, advanced stage (Binet B/C or Rai I–IV) 1, age >65 1; max 10. Low 0–1, intermediate 2–3, high 4–6, very_high 7–10. Deterministic published score with citation; not a CLL diagnosis; not Shipp IPI; not MIPI. magent does not assay TP53, IGHV, or beta-2 microglobulin.","service_name":"magent","declared_category":null,"declared_tags":["cll-ipi","cll","hematology","prognosis","calculator"],"route_template":null,"registry_updated":"2026-09-28T15:08:50.468Z"},"derived":{"note":"fields no registry supplies; TOLL derives them and marks them derived on the page","title":"calc cll ipi","category":"other","first_observed_by_toll":"2026-09-28T13:51:25.436Z","last_observed_by_toll":"2026-09-30T22:14:11.940Z","observation_began":"2026-09-10"},"presence":{"listed_now":true,"first_absent_at":null,"delisting_confirmed_at":null,"events":[{"registry":"cdp","at":"2026-09-28T13:51:25.437Z","event":"listed"}]},"accepts":[{"registry":"cdp","ordinal":0,"network":"eip155:8453","asset":"0x833589fcd6edb6e08f4c7c32d4f71b54bda02913","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.005 USDC","amount_units":0.005,"decimals_known":true,"pay_to":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"counters":{"observed_at":"2026-09-30T22:14:11.940Z","calls_30d":1,"unique_payers_30d":1,"last_called_at":"2026-09-28T15:08:50.309Z"},"validation":{"latest":{"observed_at":"2026-09-30T07:03:12.808Z","state":"pass","failed_checks":[],"endpoint_http_status":402,"run_id":"daily-2026-09-30"},"uptime":[{"days":7,"observed":4,"passed":4,"ratio":1},{"days":30,"observed":4,"passed":4,"ratio":1},{"days":90,"observed":4,"passed":4,"ratio":1}],"history_90d":[{"observed_at":"2026-09-30T07:03:12.808Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-30","state_changed":false},{"observed_at":"2026-09-29T19:20:59.346Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-29","state_changed":false},{"observed_at":"2026-09-28T16:56:57.002Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-28","state_changed":false},{"observed_at":"2026-09-28T16:42:51.917Z","state":"pass","failed_checks":[],"run_id":"new-after-daily-2026-09-28","state_changed":true}]},"seller":{"wallet":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","page":"https://tollindex.com/seller/0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","endpoints":844,"hosts":1},"reports":0,"registry_record":{"cdp":[{"tags":["cll-ipi","cll","hematology","prognosis","calculator"],"type":"http","accepts":[{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/cll_ipi","assetTransferMethod":"eip3009"},"payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","amount":"5000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":600}],"quality":{"lastCalledAt":"2026-09-28T15:08:50.309Z","l30DaysTotalCalls":1,"l30DaysUniquePayers":1},"resource":"https://api.magentlab.com/api/calc/cll_ipi","extensions":{"bazaar":{"info":{"input":{"body":{"items":[{"age":50,"tp53_abnormal":false,"advanced_stage":false,"ighv_unmutated":false,"beta2_microglobulin_mg_l":2},{"age":50,"tp53_abnormal":false,"advanced_stage":false,"ighv_unmutated":false,"beta2_microglobulin_mg_l":2}]},"type":"http","method":"POST"},"output":{"type":"json","example":{"path":"/api/calc/cll_ipi","count":2,"items":[{"score":0,"formula":"cll_ipi","citation":{"id":"cll-ipi-2016","doi":"10.1016/S1470-2045(16)30029-8","pmid":"27153538","title":"An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI)","source":"Lancet Oncol. 2016;17(6):779-790","authors":"The International CLL-IPI working group"},"age_years":50,"max_score":10,"components":[{"factor":"tp53_abnormal","points":0,"present":false},{"factor":"ighv_unmutated","points":0,"present":false},{"value":2,"factor":"beta2_microglobulin_gt_3_5","points":0,"present":false},{"factor":"advanced_stage","points":0,"present":false},{"value":50,"factor":"age_gt_65","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","risk_group":"low","formula_expression":"CLL-IPI = tp53_abnormal 4 + ighv_unmutated 2 + beta2_microglobulin_gt_3_5 2 + advanced_stage 1 + age_gt_65 1; International CLL-IPI working group 2016; max 10; low 0-1, intermediate 2-3, high 4-6, very_high 7-10","beta2_microglobulin_mg_l":2},{"score":0,"formula":"cll_ipi","citation":{"id":"cll-ipi-2016","doi":"10.1016/S1470-2045(16)30029-8","pmid":"27153538","title":"An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI)","source":"Lancet Oncol. 2016;17(6):779-790","authors":"The International CLL-IPI working group"},"age_years":50,"max_score":10,"components":[{"factor":"tp53_abnormal","points":0,"present":false},{"factor":"ighv_unmutated","points":0,"present":false},{"value":2,"factor":"beta2_microglobulin_gt_3_5","points":0,"present":false},{"factor":"advanced_stage","points":0,"present":false},{"value":50,"factor":"age_gt_65","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","risk_group":"low","formula_expression":"CLL-IPI = tp53_abnormal 4 + ighv_unmutated 2 + beta2_microglobulin_gt_3_5 2 + advanced_stage 1 + age_gt_65 1; International CLL-IPI working group 2016; max 10; low 0-1, intermediate 2-3, high 4-6, very_high 7-10","beta2_microglobulin_mg_l":2}]}},"iconUrl":"https://api.magentlab.com/favicon.ico"},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"body":{"type":"object","required":["items"],"properties":{"items":{"type":"array","items":{"type":"object","required":["tp53_abnormal","ighv_unmutated","beta2_microglobulin_mg_l","advanced_stage","age"],"properties":{"age":{"type":"integer","description":"Age in years (18-120). Age >65 scores 1 (CLL-IPI 2016). Age 65 is the ≤65 arm and scores 0."},"tp53_abnormal":{"type":"boolean","description":"del(17p) and/or TP53 mutation as assigned by the caller (CLL-IPI 2016). true scores 4. magent does not assay TP53."},"advanced_stage":{"type":"boolean","description":"Binet B/C or Rai I–IV as assigned by the caller (CLL-IPI 2016). true scores 1. false is Binet A / Rai 0. magent does not stage CLL."},"ighv_unmutated":{"type":"boolean","description":"Unmutated IGHV as assigned by the caller (CLL-IPI 2016). true scores 2. magent does not sequence IGHV."},"beta2_microglobulin_mg_l":{"type":"number","description":"Serum beta-2 microglobulin in mg/L (0.2-40). >3.5 scores 2 (CLL-IPI 2016). 3.5 is the ≤3.5 arm and scores 0. magent does not assay beta-2 microglobulin."}}},"maxItems":25,"minItems":1}},"additionalProperties":false},"type":{"type":"string","const":"http"},"method":{"type":"string","const":"POST"},"headers":{"type":"object","additionalProperties":{"type":"string"}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}}}},"description":"CLL-IPI 2016 for chronic lymphocytic leukaemia: TP53 abnormality (del(17p) and/or TP53 mutation) 4, unmutated IGHV 2, beta-2 microglobulin >3.5 mg/L 2, advanced stage (Binet B/C or Rai I–IV) 1, age >65 1; max 10. Low 0–1, intermediate 2–3, high 4–6, very_high 7–10. Deterministic published score with citation; not a CLL diagnosis; not Shipp IPI; not MIPI. magent does not assay TP53, IGHV, or beta-2 microglobulin.","lastUpdated":"2026-09-28T15:08:50.468Z","serviceName":"magent","x402Version":2}]}}